DNA Repair Inhibitors: Potential Targets and Partners for Targeted Radionuclide Therapy

por Obata, Honoka, Ogawa, Mikako, Zalutsky, Michael R.
Publicado 2023

Observations on the Effects of Residualization and Dehalogenation on the Utility of N-Succinimidyl Ester Acylation Agents for Radioiodination of the Internalizing Antibody Trastuzu...

por Chitneni, Satish K., Koumarianou, Eftychia, Vaidyanathan, Ganesan, Zalutsky, Michael R.
Publicado 2019

Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy

por Jannetti, Stephen A., Zeglis, Brian M., Zalutsky, Michael R., Reiner, Thomas
Publicado 2020

Feasibility of Developing Radiotracers for MDM2: Synthesis and Preliminary Evaluation of an (18)F-Labeled Analogue of the MDM2 Inhibitor SP-141

por Chitneni, Satish K., Zhou, Zhengyuan, Watts, Brian E., Zalutsky, Michael R.
Publicado 2021

d-Amino Acid Peptide Residualizing Agents for Protein Radioiodination: Effect of Aspartate for Glutamate Substitution

por Pruszynski, Marek, Kang, Choong Mo, Koumarianou, Eftychia, Vaidyanathan, Ganesan, Zalutsky, Michael R.
Publicado 2018

Gold Nanostars: A Novel Platform for Developing (211)At-Labeled Agents for Targeted Alpha-Particle Therapy

por Liu, Yang, Zhou, Zhengyuan, Feng, Yutian, Zhao, Xiao-Guang, Vaidyanathan, Ganesan, Zalutsky, Michael R, Vo-Dinh, Tuan
Publicado 2021

Modular nanotransporters: a versatile approach for enhancing nuclear delivery and cytotoxicity of Auger electron-emitting (125)I

por Slastnikova, Tatiana A, Koumarianou, Eftychia, Rosenkranz, Andrey A, Vaidyanathan, Ganesan, Lupanova, Tatiana N, Sobolev, Alexander S, Zalutsky, Michael R
Publicado 2012

Modular nanotransporters: a multipurpose in vivo working platform for targeted drug delivery

por Slastnikova, Tatiana A, Rosenkranz, Andrey A, Gulak, Pavel V, Schiffelers, Raymond M, Lupanova, Tatiana N, Khramtsov, Yuri V, Zalutsky, Michael R, Sobolev, Alexander S
Publicado 2012

Low-level whole-brain radiation enhances theranostic potential of single-domain antibody fragments for human epidermal growth factor receptor type 2 (HER2)-positive brain metastase...

por Procissi, Daniele, Jannetti, Stephen A, Zannikou, Markella, Zhou, Zhengyuan, McDougald, Darryl, Kanojia, Deepak, Zhang, Hui, Burdett, Kirsten, Vaidyanathan, Ganesan, Zalutsky, Michael R, Balyasnikova, Irina V
Publicado 2022

Preparation, cytotoxicity, and in vivo antitumor efficacy of (111)In-labeled modular nanotransporters

por Slastnikova, Tatiana A, Rosenkranz, Andrey A, Morozova, Natalia B, Vorontsova, Maria S, Petriev, Vasiliy M, Lupanova, Tatiana N, Ulasov, Alexey V, Zalutsky, Michael R, Yakubovskaya, Raisa I, Sobolev, Alexander S
Publicado 2017

Evaluation of an (131)I-labeled HER2-specific single domain antibody fragment for the radiopharmaceutical therapy of HER2-expressing cancers

por Feng, Yutian, Meshaw, Rebecca, McDougald, Darryl, Zhou, Zhengyuan, Zhao, Xiao-Guang, Jannetti, Stephen A., Reiman, Robert E., Pippen, Erica, Marjoram, Robin, Schaal, Jeffrey L., Vaidyanathan, Ganesan, Zalutsky, Michael R.
Publicado 2022

A Plasmonic Gold Nanostar Theranostic Probe for In Vivo Tumor Imaging and Photothermal Therapy

por Liu, Yang, Ashton, Jeffrey R., Moding, Everett J., Yuan, Hsiangkuo, Register, Janna K., Fales, Andrew M., Choi, Jaeyeon, Whitley, Melodi J., Zhao, Xiaoguang, Qi, Yi, Ma, Yan, Vaidyanathan, Ganesan, Zalutsky, Michael R., Kirsch, David G., Badea, Cristian T., Vo-Dinh, Tuan
Publicado 2015

Pharmacodynamic study of radium-223 in men with bone metastatic castration resistant prostate cancer

por Armstrong, Andrew J., Gupta, Santosh, Healy, Patrick, Kemeny, Gabor, Leith, Beth, Zalutsky, Michael R., Spritzer, Charles, Davies, Catrin, Rothwell, Colin, Ware, Kathryn, Somarelli, Jason A., Wood, Kris, Ribar, Thomas, Giannakakou, Paraskevi, Zhang, Jiaren, Gerber, Drew, Anand, Monika, Foo, Wen-Chi, Halabi, Susan, Gregory, Simon G., George, Daniel J.
Publicado 2019